
Results
4
Most Popular Stocks on the market
4 companies
AFT Pharmaceuticals
Market Cap: NZ$376.5m
Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$3.57
7D
-1.7%
1Y
32.2%
Pacific Edge
Market Cap: NZ$180.0m
A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.
PEB
NZ$0.18
7D
-6.8%
1Y
45.1%
BLIS Technologies
Market Cap: NZ$20.5m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America.
BLT
NZ$0.016
7D
0%
1Y
6.7%
Rua Bioscience
Market Cap: NZ$10.5m
Engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally.
RUA
NZ$0.031
7D
-6.1%
1Y
24.0%